Tracking Post-Approval Study Completion: Majority On-Schedule but Not Submitted
By Zachary Brennan -
Published 07 December 2017
The US Food and Drug Administration (FDA) on Thursday released its most recent report tracking the progress that new drug and biologic applicants are making on post-approval studies.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Government affairs, Regulatory intelligence, Regulatory strategy, Research and development
Tags: post-approval studies, research requirements, post-marketing research